APRIL showers put a spring in the step of CLL cells

Leukemia Research

Volumn 33, Issue 10, 2009, Pages 1306-1307

  Pepper, Chris ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; EDITORIAL; HUMAN; LYMPHOCYTOSIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PROGNOSIS; SIGNAL TRANSDUCTION; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 67649311433     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.04.031     Document Type: Editorial

References (14)

1. Collins R.J., Verschuer L.A., Harmon B.V., et al. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 71 (1989) 343-350
2. Ghia P., and Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade cell neoplasms. Adv Cancer Res 79 (2000) 157-173
3. Haiat S., Billard C., Quincey C., et al. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunolology 118 (2006) 281-292
4. Novak A., Bram R., Kay N., and Jelinek D. Aberrant expression of B-lymphocyte stimulator by B-chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100 (2002) 2973-2979
5. Kern C., Cornuel J.F., Billard C., et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103 (2004) 679-688
6. Burger J.A., Tsukada N., Burger M., Zvaifler N.J., Dell'Aquila M., and Kipps T.J. Blood-derived nurse cells protect chronic lymphocytic leukemia B-cells from spontaneous apoptosis through stromal-derived factor-1. Blood 96 (2000) 2655-2663
7. Nishio M., Endo T., Tsukada N., et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1a. Blood 106 (2005) 1012-1020
8. Hewamana S., Lin T.T., Rowntree C., et al. Rel A is an independent biomarker of clinical outcome in chronic lymphocytic leukemia. J Clin Oncol 27 (2009) 763-769
9. Cuni S., Perez-Aciego P., Perez-Chacon G., et al. A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukaemia B cells. Leukemia 18 (2004) 1391-1400
10. Furman R.R., Asgary Z., Mascarenhas J.O., Liou H.C., and Schattner E.J. Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 164 (2000) 2200-2206
11. Edelmann J., Klein-Hitpass L., Carpinteiro, et al. Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res 32 (2008) 1565-1572
12. Seshasayee D., Valdez P., Yan M., et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 (2003) 279-288
13. Moreaux J., Cremer F.W., Reme T., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106 (2005) 1021-1030
14. Hendriks J., Planelles L., de Jong-Odding J., et al. Heparin sulfateproteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Diff 12 (2005) 637-648